首页> 外文期刊>International journal of dermatology >Management of tolerance induction in patients with suspected penicillin allergy--a case study.
【24h】

Management of tolerance induction in patients with suspected penicillin allergy--a case study.

机译:可疑青霉素过敏患者的耐受性诱导管理-案例研究

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In some diseases penicillin is the treatment of choice. Case studies have shown a good response for the treatment of circumscribed scleroderma or scleroderma adultorum of Buschke. A suspected allergy to penicillin in a patient's history may limit this helpful therapy option. Allergy testing is often inconclusive. If indicated, tolerance induction leading to therapy with penicillin can be carried out. PATIENTS AND METHODS: We present two patients with circumscribed sclerosis and scleredema Buschke, who had a suspected allergy to penicillin. Due to limited therapy options and in insufficient response to other therapeutics, the decision for a tolerance induction with penicillin was made. Penicillin was successfully administered by following a scheme of tolerance induction starting with oral doses and ending with high doses of intravenous penicillin G. RESULTS: In both cases, penicillin G, administered over a period of three weeks, was well tolerated up to the high dose of 3 x 10 Mega IU/day. Substantial clinical improvement was achieved in all cases without any complications. CONCLUSION: This case study demonstrates that a suspected allergy to penicillin does not preclude an eventual treatment with this valuable drug. Allergy testing should routinely be carried out first. If suspicion of an allergy persists, tolerance induction can be attempted according to the new scheme described here. Starting with a careful, initial oral dose regimen, treatment can be continued with an increasing intravenous dose followed by maintenance therapy with high-dose penicillin G. It should be clear that this policy is only restricted for patients who are at risk for a hypersensitivity to penicillin, i.e., because of a clinical manifested incompatibility in the past.
机译:背景:在某些疾病中,青霉素是首选治疗方法。案例研究表明,对于布施克的外接硬皮病或成人硬皮病,治疗效果良好。在患者病史中怀疑对青霉素过敏可能会限制这种有用的治疗选择。过敏测试通常是不确定的。如果有指示,可以进行诱导耐受性的青霉素治疗。患者与方法:我们介绍了两名患有局限性硬化症和硬化性布希克病的患者,他们怀疑对青霉素过敏。由于有限的治疗选择以及对其他治疗方法的反应不足,因此做出了诱导青霉素耐受性的决定。按照从口服剂量开始到大剂量静脉注射青霉素G的耐受诱导方案成功施用了青霉素。结果:在这两种情况下,持续三周的青霉素G耐受性良好,直至高剂量每天3 x 10兆IU。在所有情况下都实现了实质性的临床改善,没有任何并发​​症。结论:本案例研究表明,怀疑对青霉素过敏并不能排除最终用这种有价值的药物治疗的可能性。过敏测试应首先常规进行。如果怀疑仍然存在过敏,可以根据此处描述的新方案尝试诱导耐受性。从仔细的初始口服剂量方案开始,可以通过增加静脉注射剂量继续治疗,然后继续使用大剂量青霉素G进行维持治疗。应该清楚的是,该政策仅适用于对下列药物过敏的患者青霉素,即过去由于临床表现不相容。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号